Emily Schapira Lebow, MD
Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor
Penn Medicine Provider

About me

  • Helene Blum Assistant Professor

Education and training

  • Medical School: Harvard Medical School
  • Residency: Memorial Sloan-Kettering Cancer Center

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Lebow is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Rachel Jaber Chehayeb MD a, Paulina Coutifaris MD a, b, Fawn Whitea, Jonathan Heintz MSc, Saya Jacob MDb, Jennifer Zhang MDb, Lola Fayanju MDb, Emily Lebrow MDb, Neil K. Taunk MDd, Kimberley Lee, MD, Hayley Knollman MDb, Igor Makhlin MDb, Amy S. Clark MD MSCEb, Rachel C. Jankowitz MDb, Anupma Nayak MDb, Susan Domchek MDb, Angela DeMichele MDb, Payal D. Shah, MDb Factors associated with pCR and distant recurrence in patients with early-stage TNBC treated with KN522 , San Antonio Breast Conference: 2025


Ian Messing, Lauren Linkowski, Xingmei Wang, Michael Kallan, Harper G. Hubbeling, Robert A. Lustig, Jay F. Dorsey, Goldie Kurtz, Suneel Nagda, Ahron Flowers, John Y.K. Lee, Nduka M. Amankulor, Christina Jackson, Suyash Mohan, J. Nicholas Lukens, Lynn M. Schuchter, Ravi K. Amaravadi, Alexander C. Haung, Tara Mitchell, Michelle Alonso-Basanta, Emily S. Lebow Outcomes of SRS and Ipilimumab/Nivolumab Among Patients with Melanoma Brain Metastases , Society for Neuro-Oncology (SNO) Annual Meeting, Honolulu, Hawaii : 2025


Friedes C, Berger M, Linkowski L, Hollawell C, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Nasrallah M, Nabavizadeh A, Brem S, Lee JYK, O’Rourke DM, Amankulor NM, Bagley SJ, Mohan S, Hubbeling H, Alonso-Basanta M, Lebow ES. A Real-World Analysis of Clinical Prognostic Factors Influencing Survival in Patients with High-Grade Glioma (HGG) Receiving Radiotherapy (RT) , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California: 2025


A Choi, GD Kao, CE Hill-Kayser, HG Hubbeling, ES Lebow, S Ramesh, JR Rocchetti, R McBeth, MJ LaRiviere Clinical Evaluation of AI-Generated Contours for Pediatric Proton CSI: A Blinded Expert Review , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California : 2025


onas Willmann, Edward Christopher Dee, Emily S Lebow, Caroline G McCarthy, Luke Roy George Pike, Madison Pollastro, Yonina R Murciano-Goroff, Michael Offin, Pedram Razavi, Bob T Li, Alexander E Drilon, Gregory J Riely, Helena Alexandra Yu, David R Jones, Puneeth Iyengar, Daniel Richard Gomez Durvalumab Concurrent and Following Thoracic Radiotherapy vs. Concurrent Chemoradiotherapy and Consolidation Durvalumab in Locally Advanced Non-Small Cell Lung Cancer: A Propensity Matched Analysis of a Prospective Trial , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California : 2025


Riina M, Lebow ES, Yamada Y, Wilcox J, Pike LRG, Imber BS, Messing I, Lustig RA, Hubbeling HG, Kurtz G, Alonso-Basanta M, Seidman D, Pentsova E, Boire A, Yang JT, Yu Y. Proton craniospinal radiotherapy for leptomeningeal disease from patients with metastatic solid tumors: A multi-institutional retrospective analysis , American Society for Radiation Oncology (ASTRO) Annual Meeting, San Francisco, CA: 2025


Berger M, Friedes C, Linkowski L, Hollawell C, Hubbeling H, Lustig RA, Kurtz G, Dorsey JF, Desai AS, Phillips RE, Nasrallah MP, Nabavizadeh A, Brem S, Lee JYK, O’Rourke DM, Amankulor NM, Bagley SJ, Mohan S, Alonso-Basanta M, Lebow ES Clinical and Dosimetric Predictors of Severe Radiation-Induced Lymphopenia in Patients with Glioblastoma Undergoing Adjuvant Radiotherapy , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California: 2025


Messing I, Riina M, Linkowski L, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Nagda S, Kolker J, Kurtz G, Amankulor NM, Jackson C, Cajigas I, Lee JYK, DeMichele A, Clark A, Shah P, Alonso-Basanta M, Lebow ES. Survival and CNS Disease Control Among Patients with HER2 Low Versus HER2 High Metastatic Breast Cancer with Brain Metastases Treated with SRS , American Society of Radiation Oncology (ASTRO) Annual Meeting, San Francisco, California: 2025


Messing I, Linkowski L, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Kurtz G, Nagda S, Flowers A, Lee JYK, Amankulor NM, Jackson C, Mohan S, Lukens JN, Schuchter LM, Amaravadi RK, Haung AC, Mitchell T, Alonso-Basanta M, Lebow ES. Outcomes after SRS and ipi/nivo for patients with melanoma brain metastases , American Society for Clinical Oncology (ASCO) - Society for Neuro-Oncology (SNO) Annual Meeting, Baltimore, Maryland: 2025


Stalker M, Walker SL, Lebow E, Pai EL, Watts A, Hwang WT, Banihashemi A, Anderson E, Roshkovan L, Katz SI, Litzky L, Haas AR, Singhal S, Langer CJ, Cengel K, Marmarelis ME. Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy , JTO Clin Res Rep, 6: 2025,100823